Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2019

19.12.2018 | Gynecologic Oncology

Oral etoposide for metastatic choriocarcinoma: a case report and review of guidelines

verfasst von: Georg-Peter Breitbach, Panagiotis Sklavounos, Christian Veith, Serban-Dan Costa, Walther Kuhn, Erich-Franz Solomayer, Ingolf Juhasz-Boess, Clemens Tempfer

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

Choriocarcinoma (CCA) is a rare form of malignant trophoblastic disease. Systemic polychemotherapy with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMA/CO) is the mainstay of treatment for metastatic disease. Due to the rarity of the condition, however, the evidence basis for this management is small and other chemotherapy regimens may also be effective. The reported case presents anecdotal evidence of an effective etoposide monotherapy treatment.

Method: case presentation

We report the case of a patient with gestational choriocarcinoma and pulmonary metastases initially treated with methotrexate. Due to local disease progression, she underwent hysterectomy and continued treatment with methotrexate. After pulmonary progression, she was switched to oral etoposide.

Results

After four cycles of etoposide monotherapy at a oral dosage of 100 mg d1–7, q28, the patient had no evidence of disease according to human chorionic gonadotropin serum levels and imaging studies. The treatment was well tolerated with World Health Organization (WHO) grade 2 alopecia and hot flushes as the most prominent side effects. The patient has achieved a sustained complete remission with a follow-up of 6 years.

Conclusion

Oral etoposide may be an effective treatment alternative to EMA/CO in selected patients with oligometastatic CCA.
Literatur
1.
Zurück zum Zitat Ngan HY, Bender H, Benedet JL, Jones H, Montruccoli GC, Pecorelli S, FIGO Committe on Gynecologic Oncology (2003) Gestational trophoblastic neoplasia: FIGO 2000 staging and classification. Int J Gynaecol Obstet. 83(Suppl. 1):175–177CrossRefPubMed Ngan HY, Bender H, Benedet JL, Jones H, Montruccoli GC, Pecorelli S, FIGO Committe on Gynecologic Oncology (2003) Gestational trophoblastic neoplasia: FIGO 2000 staging and classification. Int J Gynaecol Obstet. 83(Suppl. 1):175–177CrossRefPubMed
2.
Zurück zum Zitat Brown J, Naumann RW, Seckl MJ, Schink J (2017) 15 years of progress in gestational trophoblastic disease: scoring, standardization, and salvage. Gynecol Oncol 144(1):200–207CrossRefPubMed Brown J, Naumann RW, Seckl MJ, Schink J (2017) 15 years of progress in gestational trophoblastic disease: scoring, standardization, and salvage. Gynecol Oncol 144(1):200–207CrossRefPubMed
3.
Zurück zum Zitat Fisher RA, Newlands ES, Jeffreys AJ, Boxer GM, Begent RH, Rustin GJ et al (1992) Gestational and nongestational trophoblastic tumors distinguished by DNA analysis. Cancer 69(3):839–845CrossRefPubMed Fisher RA, Newlands ES, Jeffreys AJ, Boxer GM, Begent RH, Rustin GJ et al (1992) Gestational and nongestational trophoblastic tumors distinguished by DNA analysis. Cancer 69(3):839–845CrossRefPubMed
4.
Zurück zum Zitat Dilek S, Pata O, Tok E, Polat A (2004) Extraovarian nongestational choriocarcinoma in a postmenopausal woman. Int J Gynecol Cancer. 14(5):1033–1035CrossRefPubMed Dilek S, Pata O, Tok E, Polat A (2004) Extraovarian nongestational choriocarcinoma in a postmenopausal woman. Int J Gynecol Cancer. 14(5):1033–1035CrossRefPubMed
5.
Zurück zum Zitat Ramarajapalli ML, Rao NA, Murudaraju P, Kilara NG (2012) Ovarian choriocarcinoma with concurrent metastases to the spleen and adrenal glands first case report. J Gynecol Surg. 28(2):153–155CrossRef Ramarajapalli ML, Rao NA, Murudaraju P, Kilara NG (2012) Ovarian choriocarcinoma with concurrent metastases to the spleen and adrenal glands first case report. J Gynecol Surg. 28(2):153–155CrossRef
6.
Zurück zum Zitat FIGO Oncology Committee (2002) FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynaecol Obstet 77:285–287CrossRef FIGO Oncology Committee (2002) FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynaecol Obstet 77:285–287CrossRef
7.
Zurück zum Zitat Alifrangis C, Agarwal R, Short D, Fisher RA, Sebire NJ, Harvey R et al (2013) EMA/CO for high-risk gestational trophoblastic neoplasia good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. J Clin Oncol 31(2):280–286CrossRefPubMed Alifrangis C, Agarwal R, Short D, Fisher RA, Sebire NJ, Harvey R et al (2013) EMA/CO for high-risk gestational trophoblastic neoplasia good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. J Clin Oncol 31(2):280–286CrossRefPubMed
8.
Zurück zum Zitat Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA (2016) Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 1:CD008891 Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA (2016) Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 1:CD008891
9.
Zurück zum Zitat Taylor F, Short D, Winter MC, Tidy J, Savage PM, Sarwar N, Hancock BW, Seckl MJ, Coleman RE (2015) A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom. Gynecol Oncol 136(2):258–263CrossRefPubMed Taylor F, Short D, Winter MC, Tidy J, Savage PM, Sarwar N, Hancock BW, Seckl MJ, Coleman RE (2015) A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom. Gynecol Oncol 136(2):258–263CrossRefPubMed
10.
Zurück zum Zitat Gupta M, Vang R, Yemelyanova AV, Kurman RJ, Li FR, Maambo EC, Murphy KM, DeScipio C, Thompson CB, Ronnett BM (2012) Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists. Am J Surg Pathol 36(12):1747–1760CrossRefPubMedPubMedCentral Gupta M, Vang R, Yemelyanova AV, Kurman RJ, Li FR, Maambo EC, Murphy KM, DeScipio C, Thompson CB, Ronnett BM (2012) Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists. Am J Surg Pathol 36(12):1747–1760CrossRefPubMedPubMedCentral
Metadaten
Titel
Oral etoposide for metastatic choriocarcinoma: a case report and review of guidelines
verfasst von
Georg-Peter Breitbach
Panagiotis Sklavounos
Christian Veith
Serban-Dan Costa
Walther Kuhn
Erich-Franz Solomayer
Ingolf Juhasz-Boess
Clemens Tempfer
Publikationsdatum
19.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2019
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-018-5016-x

Weitere Artikel der Ausgabe 4/2019

Archives of Gynecology and Obstetrics 4/2019 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.